Literature DB >> 18516319

The angiogenesis in colorectal carcinomas with and without lymph node metastases.

Simona Gurzu1, J Jung, L Azamfirei, T Mezei, Anca Maria Cîmpean, Z Szentirmay.   

Abstract

UNLABELLED: Many clinical trials revealed that the anti-angiogenic treatment could improve prognosis in patients with metastatic colorectal carcinomas (CRC), when added to standard chemotherapy. In this paper, we tried to find out if the microvascular density (MVD) determined with CD31, CD105 was correlated with lymph node status, and if the intensity of angiogenesis was different in right versus left colon segments. We studied 187 CRC, with and without lymph node metastases, 128 from left and 59 from right colon.
RESULTS: In the right colon, the MVD was higher in the cases where the lymph nodes did not present metastases (pN0) but also when four or more lymph nodes were involved (pN2). In the rectum and sigma, the angiogenesis presented the highest intensity in pN0 and pN1 stage (1-3 lymph nodes with metastases), decreasing in pN2 stage. In the descendent colon segment, the MVD did not present differences between the cases with and without lymph node metastases.
CONCLUSIONS: Our study reveals that the most indicated cases for antiangiogenic treatment seem to be the pN0 and pN1 cases in the rectum and sigma, respectively pN0 and pN2 cases in the right colon. We tend to believe that the angiogenesis intensity in CRC is higher in early-stages of the tumoral proliferation but it is not an increasing process, having rather an oscillating character. Therefore, the angiogenesis remains an independent prognostic and predictive factor and the antiangiogenic treatment is necessary to be individualized for each patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516319

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  12 in total

Review 1.  Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer.

Authors:  Simona Gurzu; Camelia Silveanu; Annamaria Fetyko; Vlad Butiurca; Zsolt Kovacs; Ioan Jung
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

2.  Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies.

Authors:  Sandra F Martins; Rui M Reis; Antonio Mesquita Rodrigues; Fátima Baltazar; Adhemar Longatto Filho
Journal:  World J Clin Oncol       Date:  2011-06-10

3.  Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study.

Authors:  Ban J Qasim; Hussam H Ali; Alaa G Hussein
Journal:  Saudi J Gastroenterol       Date:  2012 Jul-Aug       Impact factor: 2.485

4.  Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans.

Authors:  Young Joo Jeon; Jong Woo Kim; Hye Mi Park; Hyo Geun Jang; Jung O Kim; Jisu Oh; So Young Chong; Sung Won Kwon; Eo Jin Kim; Doyeun Oh; Nam Keun Kim
Journal:  BMC Cancer       Date:  2014-11-25       Impact factor: 4.430

5.  Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations.

Authors:  George Emmanouil; George Ayiomamitis; Adamantia Zizi-Sermpetzoglou; Maria Tzardi; Andrew Moursellas; Argyro Voumvouraki; Elias Kouroumalis
Journal:  Anal Cell Pathol (Amst)       Date:  2018-04-16       Impact factor: 2.916

6.  Apatinib as an optional treatment in metastatic colorectal cancer.

Authors:  Aiyi Li; Kong Wang; Aiguo Xu; Gang Wang; Yongchang Miao; Zhichao Sun; Jingyu Zhang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 7.  Subcellular Expression of Maspin in Colorectal Cancer: Friend or Foe.

Authors:  Simona Gurzu; Ioan Jung
Journal:  Cancers (Basel)       Date:  2021-01-20       Impact factor: 6.639

8.  Development of a Nomogram Combining Clinical Risk Factors and Dual-Energy Spectral CT Parameters for the Preoperative Prediction of Lymph Node Metastasis in Patients With Colorectal Cancer.

Authors:  Yuntai Cao; Jing Zhang; Haihua Bao; Guojin Zhang; Xiaohong Yan; Zhan Wang; Jialiang Ren; Yanjun Chai; Zhiyong Zhao; Junlin Zhou
Journal:  Front Oncol       Date:  2021-09-22       Impact factor: 6.244

9.  Correlation between vascular endothelial growth factor-A expression and tumor location and invasion in patients with colorectal cancer.

Authors:  Susanna Hilda Hutajulu; Dewi Kartikawati Paramita; Joyo Santoso; Muhammad Ivan Aulia Sani; Aghnia Amalia; Gatri Wulandari; Ahmad Ghozali; Johan Kurnianda
Journal:  J Gastrointest Oncol       Date:  2018-12

10.  Ki-67 Expression in CRC Lymph Node Metastasis Does Not Predict Survival.

Authors:  Sandra F Martins; Ricardo Amorim; Sílvia Coelho Mota; Luís Costa; Fernando Pardal; Mesquita Rodrigues; Adhemar Longatto-Filho
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.